Michael R. Hess

Asembia is great not only for networking conversations that can lead to transactions but also for taking stock of your organization.

State regulators and legislatures are considering new requirements for controlled substance prescribing and reporting.

Many specialty pharmacies permit their sales force to engage in some degree of expenditure on referral sources, but many lack detailed guidelines, policies on prohibited activity, or spending limits.

Core services are basic to specialty pharmacy offerings, while enhanced services are only provided with payment from a third party, usually a drug manufacturer.

Specialty pharmacies need to track drug pricing throughout the claims adjudication process to avoid potential liability.

Industry stakeholders must carefully examine every detail of drug adherence programs to ensure compliance with the Anti-Kickback Statute.

Financial concerns among buyers and sellers of specialty pharmacies often take precedence over concise operational documentation that can kill a potential deal.

Specialty pharmacies need to carefully evaluate multiple aspects of manufacturer-sponsored free product programs.

There are several key factors a specialty pharmacy must consider when deciding whether to participate in a limited distribution network.

Specialty pharmacies must consider how their marketing programs intersect with Health Insurance Portability and Accountability Act marketing rules.

There are notable compliance, business, and operational implications for pharmacies involved in the use of co-pay coupons.